MMP9 and asthma: In contrast, bencycloquidium bromide, a selective M3 receptor antagonist, inhibited ovalbumin-induced expression of MMP-9 mRNA in a murine asthma model [71], indicating that M1 and M3 receptors mediate profibrotic and inflammatory response via specific MMPs.